The infection caused by the new coronavirus had its first case described in December 2019,
in Wuhan, China, and reached a pandemic status in March 2020. Since then, knowledge …

Objetivo: Compreender as manifestações clínicas neurológicas apresentadas por pacientes
com coronavírus da Síndrome Respiratória Aguda Grave 2 (SARS-CoV-2)/Doença …

O Coronavírus 2 (SARS-CoV-2), atualmente conhecido como COVID-19, responsável pela
síndrome respiratória aguda grave tornou-se um caso de Emergência de Saúde Pública de …

Background: As the COVID-19 pandemic unfolds worldwide, different forms of reports have
described its neurologic manifestations. Objective: To review the literature on neurological …

Introdução: A infecção por SARS-CoV-2 foi identificada pela primeira vez em dezembro de
2019, na China, e rapidamente espalhou-se por todo o mundo. Houve um crescente …

Recent reports indicate that besides respiratory and systemic symptoms among coronavirus
disease (COVID-19) patients, the disease has a wide spectrum of neurological …

Background: The clinical presentation of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection can range from mild or moderate disease (80% of the cases) to …

Background: As the COVID-19 pandemic unfolds worldwide, different forms of reports have
described its neurologic manifestations. Objective: To review the literature on neurological …

SARS-CoV-2 is a single-stranded RNA virus that belongs to the group of seven
coronaviruses that affect humans, and its infection causes the COVID-19 disease. The …

The Coronavirus disease due to SARS-CoV-2 emerged in Wuhan city, China in December
2019 and rapidly spread to more than 200 countries as a global health pandemic. There are …